Meta-analysis of the acute effects of nicotine and smoking on human performance - PubMed (original) (raw)
Meta-Analysis
Meta-analysis of the acute effects of nicotine and smoking on human performance
Stephen J Heishman et al. Psychopharmacology (Berl). 2010 Jul.
Abstract
Rationale and objective: Empirical studies indicate that nicotine enhances some aspects of attention and cognition, suggesting a role in the maintenance of tobacco dependence. The purpose of this review was to update the literature since our previous review (Heishman et al. Exp Clin Psychopharmacol 2:345-395, 1994) and to determine which aspects of human performance were most sensitive to the effects of nicotine and smoking.
Methods: We conducted a meta-analysis on the outcome measures of 41 double-blind, placebo-controlled laboratory studies published from 1994 to 2008. In all studies, nicotine was administered, and performance was assessed in healthy adult nonsmokers or smokers who were not tobacco-deprived or minimally deprived (<or=2 h).
Results: There were sufficient effect size data to conduct meta-analyses on nine performance domains, including motor abilities, alerting and orienting attention, and episodic and working memory. We found significant positive effects of nicotine or smoking on six domains: fine motor, alerting attention-accuracy and response time (RT), orienting attention-RT, short-term episodic memory-accuracy, and working memory-RT (effect size range = 0.16 to 0.44).
Conclusions: The significant effects of nicotine on motor abilities, attention, and memory likely represent true performance enhancement because they are not confounded by withdrawal relief. The beneficial cognitive effects of nicotine have implications for initiation of smoking and maintenance of tobacco dependence.
Similar articles
- Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers.
Kleykamp BA, Jennings JM, Eissenberg T. Kleykamp BA, et al. Exp Clin Psychopharmacol. 2011 Feb;19(1):75-84. doi: 10.1037/a0022417. Exp Clin Psychopharmacol. 2011. PMID: 21341925 Free PMC article. Clinical Trial. - Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Myers CS, Taylor RC, Moolchan ET, Heishman SJ. Myers CS, et al. Neuropsychopharmacology. 2008 Feb;33(3):588-98. doi: 10.1038/sj.npp.1301425. Epub 2007 Apr 18. Neuropsychopharmacology. 2008. PMID: 17443125 Clinical Trial. - Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA. Grundey J, et al. Psychopharmacology (Berl). 2015 Jul;232(14):2491-501. doi: 10.1007/s00213-015-3880-7. Epub 2015 Feb 27. Psychopharmacology (Berl). 2015. PMID: 25721074 - Behavioral and cognitive effects of smoking: relationship to nicotine addiction.
Heishman SJ. Heishman SJ. Nicotine Tob Res. 1999;1 Suppl 2:S143-7; discussion S165-6. doi: 10.1080/14622299050011971. Nicotine Tob Res. 1999. PMID: 11768172 Review. - Smoking and Cognition.
Campos MW, Serebrisky D, Castaldelli-Maia JM. Campos MW, et al. Curr Drug Abuse Rev. 2016;9(2):76-79. doi: 10.2174/1874473709666160803101633. Curr Drug Abuse Rev. 2016. PMID: 27492358 Review.
Cited by
- Cannabis, cigarettes, and their co-occurring use: Disentangling differences in default mode network functional connectivity.
Wetherill RR, Fang Z, Jagannathan K, Childress AR, Rao H, Franklin TR. Wetherill RR, et al. Drug Alcohol Depend. 2015 Aug 1;153:116-23. doi: 10.1016/j.drugalcdep.2015.05.046. Epub 2015 Jun 10. Drug Alcohol Depend. 2015. PMID: 26094186 Free PMC article. - Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms.
Ameringer KJ, Leventhal AM. Ameringer KJ, et al. J Addict Dis. 2012;31(4):363-75. doi: 10.1080/10550887.2012.735568. J Addict Dis. 2012. PMID: 23244555 Free PMC article. - The effects of acute abstinence from smoking and performance-based rewards on performance monitoring.
Schlienz NJ, Hawk LW Jr, Rosch KS. Schlienz NJ, et al. Psychopharmacology (Berl). 2013 Oct;229(4):701-11. doi: 10.1007/s00213-013-3131-8. Epub 2013 May 17. Psychopharmacology (Berl). 2013. PMID: 23681159 Free PMC article. Clinical Trial. - Comorbid Cannabis and Tobacco Use in Adolescents and Adults.
Subramaniam P, McGlade E, Yurgelun-Todd D. Subramaniam P, et al. Curr Addict Rep. 2016 Jun 1;3(2):182-188. doi: 10.1007/s40429-016-0101-3. Curr Addict Rep. 2016. PMID: 27175326 Free PMC article. - Zebrafish as an alternative method for determining the embryo toxicity of plant products: a systematic review.
Falcão MAP, de Souza LS, Dolabella SS, Guimarães AG, Walker CIB. Falcão MAP, et al. Environ Sci Pollut Res Int. 2018 Dec;25(35):35015-35026. doi: 10.1007/s11356-018-3399-7. Epub 2018 Oct 24. Environ Sci Pollut Res Int. 2018. PMID: 30357668
References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 text revision. American Psychiatric Association; Washington: 2000.
- Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367–378. - PubMed
- Azizian A, Monterosso J, O’Neill J, London ED. Magnetic resonance imaging studies of cigarette smoking. Handb Exp Pharmacol. 2009;192:113–143. - PubMed
- Baddeley AD. Essentials of human memory. Psychology; Sussex: 1999.
- Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008a;33:480–490. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 DA007209/DA/NIDA NIH HHS/United States
- ZIA DA000483-06/ImNIH/Intramural NIH HHS/United States
- ZIA DA000484-06/ImNIH/Intramural NIH HHS/United States
- T32DA007209-29/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources